RELISH

Office:

l-2, 4th Floor, I

Opp. Gurukul,

PHARMACEUTICALS
TIMITED

Ahmedabad8o 052,
Phone: 0796652 2242

l2thFebruary,
To,
The General Manager-Listing
Corporate Relationship Department
The BSE Limite4 Ground Floor,
P.]. Towers, Dalal Street, Mumbai

Scrip Code:524632
Dear Sir,

With reference to above subject and in compliance with the Listing Agreemefl! r
hereby submit the outcome of the Board Meeting of the Members helJonLday
i.e. 1
February, 20'J,6 at01:00 p.m.:-

Approval of Unaudited Financial Results Quarter ended on 31't December ,2015.

You are requested to kindly take the suune on record.
Thanking You
Yours faithfully,
For Relish

S
Sujay
Director
DIN:02145467

Complex,

Road,
II{DLA

: 2749 8515

RELISH PHARMACEUTICALS

LTD

Statement of Standalo

Purchase of stock-in-trade
(c) changes in inventorGs

oiEiEhed

of the total expenses relating to

Profit

(Loss) from operations before

other

finance costs but before except'lonal items

Profit

(l-oss)

of profit

Profft

for the period

(rr rrZ)

(loss) of associates*

(Loss)

after taxes,

and share of profit

(loss) of

(13+14+151*
(Face Value of the Share shall be

indi"teot

balance sheet of previous accounting year

Rs.10/- each) (not annualised):

Rs.

10/- each) (not annualised):

Notes: 1. The above results were revie

Directors at its meeting held on 12th Februarv 2016
2' The company has only single Reportable Business segment

Accounting Standard 17.

3' previous quarter's figures have been re-grouped
Place: Ahmedabad

Date;!2/O2l2Ot6

in terms of requirements of

re-arranged wherever necessary.

Quarter Ended

31 I

l72}ls

Promoters and Promoter Group Sharehold-in!-i

of shares (as a % of the total

of shares (as a % of the total

of shares (as a % of the total

- Percentage of shares (as a % of the

total

are capital ofthe

Particulars

3 months

ended

31lt2l20ts
NVESTOR COMPTAINTS

)ending at the beginning

of the quarter
Received during the quarter

Disposed of during the quarter

lemaining unresolved at the end of the quan er

W"

RELISH PHARMACEUTICALS LTD

(ln

STATEMENT OF ASSETS AND LIABILITIES

STANDAL )NE
As at
As t Previous
3r.L2.20t5

(Unaudited)
A

end 31.3.201 t

At Jited)

EQUITY AND LIABILITIES

1 SHAREHOLDERS

FUNDS

(a) Share Capital

(b) Reserves and surplus

157.00

L57

L232.74

238

L389.74

195

3.60

L6

228.65

29

0.00

(c)Money received against shre warrant

SHAREHOLDERS FUNDS
2 SHARE APPLICATION MONEY PENDING ALLOTMENT
3 NON . CUURENT LIABTITIES

(a) Long-term borrowing

(b) Defered tax liabilities (net)

(c )Other long-term liabilities

(d) long-term provisions

NON - CURRENT L]ABLITIES

0.00

232.25

!45

4 CURRENT LIABILITIES
(a) Short-term borrowing

38

(b)Trade payables
@ Other cuurent laibilities
(d) Short- term provision

31.00

42

t.82

CURRENT LIABILITIES

32.82

88

TOTAL EqU|TY AND LIABILITIES

1654.81_

t28

ASSETS

L NON . CURRENT ASSETS

(a) Fixed assets

L132.00

40

(b) Non- current investments

@ Deferred tax assets (net)

(d) long-term loans and advances

(e) Other non-cuurent assets

NON - CURRENT ASSETS

1136

t50

2 CURRENT ASSETS
(a) Cuurents investments

(b) Inventories
Trade receivables
(d) Cash and cash equivalents
@

(e) Short-term loans and advances

rL3.29

??

45.04

48

52.44
252.45

185

49

s\

(f) Other current asets

CURRENT ASSETS

TOTAL ASSETS

53

th \.

;77

lc,P

t28

54.81

_-4
*-e